Congress mandates free lung cancer screening, removes insurer delays
H.R. 6314 — Lung Cancer Screening Expansion Act of 2025 · Filed by Ritchie Torres (D-NY) · Introduced Nov 25, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill requires all health insurers—private plans, employer plans, and federal programs—to cover annual lung cancer screening tests (low-dose CT scans) at no cost to patients aged 50–80 who are at increased risk. It bars insurers from using prior authorization, step-therapy delays, or other cost-control tactics to block or delay screening.
Why we flagged it
The bill's operative mechanism is a straightforward insurance coverage mandate for a specific preventive service. It imposes a cost on insurers and removes administrative barriers to access, with no carve-outs, exemptions, or hidden riders.
What the text implies
- Mandate applies to all federal health programs (Medicare, Medicaid, VA, federal employee plans), creating uniform coverage across public and private sectors and potentially shifting screening volume and costs across payers.
- Removal of prior authorization and step-therapy may increase screening utilization beyond current rates, raising total healthcare spending on imaging and downstream diagnostic/treatment costs.
The full analysis lists 4 implications of this text.
Who stands to gain
diagnostic imaging providers (radiology centers, hospital imaging departments); CT scanner manufacturers and service providers; pulmonology and oncology practices (downstream referrals from positive screens)